Connect with us

Health

C.D.C. Cuts Threaten to Set Back the Nation’s Health, Critics Say

Published

on

C.D.C. Cuts Threaten to Set Back the Nation’s Health, Critics Say

The extensive layoffs of federal health workers that began on Tuesday will greatly curtail the scope and influence of the Centers for Disease Control and Prevention, the world’s premier public health agency, an outcome long sought by conservatives critical of its handling of the Covid-19 pandemic.

The reorganization of the Department of Health and Human Services shrinks the C.D.C. by 2,400 employees, or roughly 18 percent of its work force, and strips away some of its core functions.

Some Democrats in Congress described the reorganization throughout H.H.S. as flatly illegal.

“You cannot decimate and restructure H.H.S. without Congress,” said Senator Patty Murray, Democrat of Washington, and a member of the Senate health committee.

“This is not only unlawful but seriously harmful — they are putting Americans’ health and well-being on the line,” she added.

Advertisement

Ms. Murray noted that the Trump administration had not detailed which units are being cut at the C.D.C. and other health agencies. Robert F. Kennedy Jr., the health secretary, said last week the layoffs would affect primarily administrative functions.

But according to information gathered by The New York Times from dozens of workers, the reductions were more broadly targeted. Scientists focused on environmental health and asthma, injuries, lead poisoning, smoking and climate change were dismissed.

Researchers studying blood disorders, violence prevention and access to vaccines were let go. The agency’s center on H.I.V. and sexually transmitted diseases was among the hardest hit, losing about 27 percent of its staff.

The National Institute for Occupational Safety and Health, which makes recommendations on how to keep workers safe, was all but dissolved.

What remains is a hobbled C.D.C., with a smaller global footprint, devoting fewer resources to environmental health, occupational health and disease prevention, public health experts said.

Advertisement

Instead, the agency will be trained more narrowly on domestic disease outbreaks. Communications will be centralized at H.H.S. in Washington.

The department intends “to ensure a more coordinated and effective response to public health challenges, ultimately benefiting the American taxpayer,” said Emily Hilliard, deputy press secretary at the department.

“C.D.C. scientists have conducted numerous interviews on a variety of topics and will continue to do so,” she added.

Critics predicted the move would prevent scientists from speaking frankly about public health.

“American taxpayers provide the resources for C.D.C.’s specialists and have the right to hear directly from them without interference by politicians,” said Dr. Thomas R. Frieden, who led the agency from 2009 to 2017.

Advertisement

The sweeping reductions arrive as the nation confronts an outbreak of measles in Texas and elsewhere, a spreading bird flu epidemic on poultry and dairy farms, and a raft of new questions about public health measures like water fluoridation and school vaccine requirements.

“What we seem to be seeing is a dismantling rather than a restructuring” of the public health system, said Dr. Richard Besser, chief executive of the Robert Wood Johnson Foundation and a former acting director of the C.D.C.

On Capitol Hill, the Senate health committee, which recommended confirmation of Mr. Kennedy as secretary, scheduled a hearing on the reorganization of H.H.S., citing the possible impacts on public health.

Mr. Kennedy has described the reorganization as an effort to clean up waste and bureaucracy while promising that federal health agencies would do more to improve the health of Americans.

“We’re going to eliminate an entire alphabet soup of departments and agencies while preserving their core functions by merging them into a new organization called the Administration for a Healthy America,” the secretary said in a videotaped message announcing the layoffs.

Advertisement

The department did not respond to requests for more detailed information.

Society’s most vulnerable — the poor, Black, Latino and Native American people, rural Americans with less access to health care, the disabled and those at highest risk for illness — are likely to be hit hardest, experts said.

“These communities rely on public health to a larger extent than wealthy communities do,” Dr. Besser said.

For decades, public health and medical research drew support across the political spectrum.

But the C.D.C. has been in the political cross hairs since the first Trump administration, when the White House muzzled the agency’s communications, meddled with its publications and blamed its scientists for bungling the pandemic response.

Advertisement

In recent years, lawmakers have harshly criticized the agency’s advice on masks, lockdowns, social distancing, school closures and various other attempts to contain the pandemic, calling them economically and socially disastrous.

Project 2025, the conservative blueprint for reshaping the federal government, described the C.D.C. as “perhaps the most incompetent and arrogant” federal agency, and called on Congress to curb its powers.

Through staffing cuts, the administration reduced critical divisions of the National Center for Injury Prevention and Control, and employees studying how to prevent gun violence, child abuse and elder abuse were fired.

Injuries are the leading cause of death among Americans under 45. About 47,000 Americans are killed by firearms each year, more than half of them suicides.

But gun violence is a politically fraught topic. Pressure from the National Rifle Association and conservative politicians led to a ban on using federal funds to study gun violence for almost 25 years. Funding was restored in 2019.

Advertisement

The injury center studied ways to improve gun safety and promoted the use of gun locks, particularly in homes where children live.

“People think of gun violence as a question for law enforcement, but the public health approach has made a big difference,” said Dr. Mark Rosenberg, a former center director.

Most of the C.D.C.’s Division of Reproductive Health, which studies maternal health, was also shuttered. Whether some or all of its portfolio will be assumed by the new organization created by Mr. Kennedy was not clear.

Pregnant women and newborns die in the United States at a far higher rate than in other industrialized nations.

In recent years, the C.D.C. focused on stark racial health disparities that put Black American women at nearly three times the risk of dying of pregnancy complications than white women.

Advertisement

But the Trump administration has been defunding studies of health disparities in racial, ethnic and gender minorities, saying they do not align with the president’s executive orders ending diversity, equity and inclusion initiatives.

Mr. Kennedy said last week that the National Institute for Occupational Safety and Health, which makes recommendations for preventing work-related injuries and illnesses, would be absorbed into the health department.

But on Tuesday, most of its divisions were eliminated, among them offices dedicated to protecting workers in various industries, including mine inspectors.

Even one of the agency’s most essential functions, infectious disease research, was affected.

The Trump administration had been weighing moving the H.I.V. prevention division to a different agency within the health department.

Advertisement

But on Tuesday, teams leading H.I.V. surveillance and research within that division were laid off. It was unclear whether some of those functions would be recreated elsewhere. (A team in the global health center working on preventing mother-to-child transmission of H.I.V. was also cut.)

Until now, the C.D.C. provided funds to states and territories for responding to and preventing H.I.V. outbreaks. Roughly one in four new diagnoses of H.I.V. is made with agency funds.

Some H.I.V. experts warned that the move could lead to a rise in H.I.V. infections among Americans.

“H.I.V. prevention is a lot more than just giving out condoms,” said Dr. John Brooks, who served as chief medical officer for the division of H.I.V. prevention until last year. “It saves lives, averts illness and produces enormous cost savings.”

Broadly, the reorganization aligns with Mr. Kennedy’s preferred emphasis on research into chronic diseases; federal research has been far too focused on infectious diseases, he has said.

Advertisement

But the line between them is not always clear, said Dr. Anne Schuchat, former principal deputy director of the C.D.C. Research that seems disconnected from outbreak response may also be a key for fighting pathogens.

“For Zika, we needed experts in birth defects, entomology and vector control, virologists and environmental health experts,” she said. “Emerging threats don’t respect borders of C.D.C. organizational units.”

The reorganization risks choking the talent pipeline for public health, said Ursula Bauer, former director of the agency’s National Center for Chronic Disease Prevention and Health Promotion.

“Once you decimate an agency like C.D.C., which is full of high-caliber highly trained individuals, building back is going to be incredibly difficult,” she said.

“It will take two to three times as long to undo the damage as it took to inflict it.”

Advertisement

The cuts also will take a toll on the agency’s ability to gather and analyze data, which are keys to identifying trends and developing interventions, Dr. Phil Huang, director of Dallas County Health and Human Services, said at a news briefing.

“You take away those systems, and it takes away the ability to see the impact of all these cuts,” he added.

Health

What to Know About Orphines, a New Class of Deadly Opioids

Published

on

What to Know About Orphines, a New Class of Deadly Opioids

Since last fall, new and deadly synthetic opioids called orphines have begun appearing in street drugs in the United States. They are far more potent than fentanyl but cannot be detected by standard toxicology tests.

Orphines are still much less common than fentanyl, but they are proliferating quickly. As of last month, they have been found in 14 states, mostly in the South and the Midwest. Law enforcement officials and public health officials are trying to assess the gravity and endurance of the threat they pose.

Here are answers to some basic questions.

They are a class of opioids that was created in the 1960s by Paul Janssen, a Belgian doctor and pharmacologist, whose teams investigated rapid, safe pain relievers for surgery. As part of that effort, they also developed fentanyl.

Dr. Janssen and others discovered that orphines had life-threatening side effects such as acute respiratory depression and were highly addictive. Within a few years, the research on them was halted.

Advertisement

Researchers characterize orphines as 10 times more powerful than fentanyl, even in quantities no greater than a few sand-size grains. They can be lethal with stunning speed, with victims slumping over abruptly, respiration shutting down, chest walls rigid. Sometimes the classic signature of overdose, “the foam cone” — froth from the nostrils and mouth — does not even have time to bubble up.

Still, it is possible for people overdosing on orphines to be revived with naloxone, the opioid reversal medication. But numerous doses may be required, many more than the one or two doses typically needed for fentanyl.

Advertisement

Orphines are among the synthetic opioids that started to appear in the street drug supply in the wake of global crackdowns on fentanyl.

In 2018, the Drug Enforcement Administration issued a temporary ban on all fentanyl-related substances, called analogs. That same year, an article in The Journal of Medicinal Chemistry addressed the challenge of developing opioids without toxic side effects and offered orphines as cautionary examples. It described them as dangerous, because they are so powerfully addictive and may affect breathing.

Researchers speculate that rogue chemists, seeking illicit drugs that can evade international drug laws, may have been inspired by the article to develop orphines. By 2019, brorphine, an early orphine, was detected in Europe.

Around that time, another class of cheap, synthetic opioids called nitazenes had been circulating in Europe and the United States, alarming law enforcement and public health officials. But in July 2025, China, a key manufacturing source of chemicals for nitazenes, banned them.

Nitazenes began to fade but, within months, orphines popped up in the American illicit drug supply.

Advertisement

The most common orphine is an analog called cychlorphine (also known as N-propionitrile chlorphine). It seems to be circulating in counterfeit pills or as a powder, bulking and boosting fentanyl. Overdoses and fatalities may occur because the user did not know that the intended drug — such as the stimulant methamphetamine — had been adulterated with the orphine.

Cychlorphine is so new, so difficult to seize that researchers believe it is often being delivered by international mail. In addition to the United States, it has been detected in Estonia, Latvia and Lithuania, France and Germany, where, cheap and available, it has been nicknamed “poor man’s fentanyl.”

There are indications in Europe that cychlorphine is being used on its own, not just to adulterate other drugs. Medical examiners in the United States are starting to surmise this as well because a few overdose fatalities do not test positive for conventional illicit drugs, like fentanyl and benzodiazepines. When further toxicology tests have been done, cychlorphine shows up as the only deadly drug on board.

Continue Reading

Health

Vision problem leads to man’s stage 4 lung cancer diagnosis, new drug extends survival

Published

on

Vision problem leads to man’s stage 4 lung cancer diagnosis, new drug extends survival

NEWYou can now listen to Fox News articles!

A former Ironman triathlete was stunned to learn that his vision problems were actually the first sign of stage 4 lung cancer.

Dave Nitsche, 57, was initially given just 12 to 24 months to live – but a newly approved drug has helped him surpass that timeframe by several years.

“In 2019, I noticed that I was having trouble seeing with my left eye,” the Canadian man shared during an interview with Fox News Digital. “I went to the optometrist, and they said it was probably a detached retina.”

DOCTOR AND CANCER SURVIVOR GEARS UP TO RUN 7 MARATHONS ON 7 CONTINENTS IN 7 DAYS

Advertisement

After scans revealed fluid buildup and rising pressure, doctors determined that Nitsche had lost vision in the eye — and ultimately removed it. A biopsy of the fluid revealed that it was cancerous.

Next, Nitsche saw more specialists, who extracted fluid from his lungs for more testing. “The next day, the oncologist told me that I had stage 4 lung cancer,” he said. 

Dave Nitsche, pictured in Calgary, Alberta in 2025, was stunned to learn that his vision problems were actually the first sign of stage 4 lung cancer. (Dave Nitsche)

Nitsche said his doctors were “very shocked” to find that his initial eye issues had stemmed from lung cancer – particularly because he had never been a smoker.

Azam J. Farooqui, M.D., a hematology and oncology physician at Ironwood Cancer & Research Centers in Chandler, Arizona, agreed that Nitsche’s case was “very surprising.”

Advertisement

LUNG CANCER RISING AMONG NON-SMOKERS — HERE’S WHY

“Cancer can find its way to some very odd locations, but the eye is a very, very rare one,” Farooqui, who did not treat Nitsche, told Fox News Digital. “Usually cancer will get there via a nerve channel or blood vessel, but it’s very uncommon.”

Nitsche, an ex-triathlete who has done multiple Ironman races, hadn’t experienced any other symptoms other than the eye issues. “I was running quite a bit at the time,” he shared. “I had a little bit of back pain here and there, but lung cancer definitely wasn’t on my radar.”

Nitsche, an ex-triathlete who has done multiple Ironman races, hadn’t experienced any other symptoms other than the eye issues. “I had a little bit of back pain here and there, but lung cancer definitely wasn’t on my radar.” (Dave Nitsche)

His first treatment was a targeted therapy called afatinib, which lasted about three months. When doctors found that the cancer had spread to Nitsche’s brain, he began taking another medication called Tagrisso (osimertinib), which crosses the blood-brain barrier.

Advertisement

HIDDEN FACTOR IN CANCER TREATMENT TIMING MAY AFFECT SURVIVAL, RESEARCHERS SAY

After six years, when those drugs stopped working, Nitsche started taking Rybrevant (amivantamab), a chemo-free drug that he receives via IV infusion every three weeks in a supervised medical setting. After a year on the drug, which is developed by Johnson & Johnson, his scans are looking “very, very good,” he said.

“There are days that you feel strong and there are days that you’re a little weaker, but you just adjust accordingly.”

“Science is catching up to me perfectly with all these drugs that I’m on,” Nitsche said. “Now, we’ll just wait for the next thing to come along, and we’ll jump onto that. But for now, the Rybrevant is working perfectly.”

Nitsche has experienced a few side effects, but said for the most part, the drug he is taking is “very tolerable.” (Dave Nitsche)

Advertisement

Nitsche has experienced a few side effects, primarily skin irritation and fingernail infections, but said for the most part, the drug is “very tolerable.”

Compared to the full-dose chemo and other lung cancer treatments, Farooqui agreed that Rybrevant is “very manageable.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Other common side effects can include infusion reactions, muscle and joint pain, mouth sores, swelling, fatigue, nausea, bowel changes, vomiting, cough, shortness of breath and low appetite, according to FDA prescribing information.

In rare cases, serious effects can include lung inflammation, blood clots, severe skin reactions and eye problems. Pregnant women should not take the drug due to fetal risks.

Advertisement

Embracing his role as an advocate, Nitsche now speaks openly about his experience and what others should know. (Dave Nitsche)

“If somebody is having too many side effects, or if it is feeling too aggressive, we can do dose reductions,” Farooqui noted. “In my experience, we’ve had patients do really well on it, and we’ve been able to manage their side effects without any major concerns.”

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

Rybrevant has now been approved to treat certain types of non-small cell lung cancer in the U.S. and Canada, and Nitsche said a few of his friends are also taking the drug.

“Doctors gave me a year to two years – they told me to get my affairs in order. And it’s been seven years now,” he said. “I’ll take it.”

Advertisement

“For almost any type of cancer, a diagnosis is not a death sentence.”

Nitsche is now preparing for a 600-mile biking expedition in June to raise awareness for lung cancer. He credits his endurance training and high fitness level with helping to extend his survival. 

“There are days that you feel strong and there are days that you’re a little weaker, but you just adjust accordingly,” he said.

Rybrevant has now been approved to treat certain types of non-small cell lung cancer in the U.S. and Canada. (iStock)

Embracing his role as an advocate, Nitsche now speaks openly about his experience and what others should know.

Advertisement

“If you have lungs, you can get lung cancer – but at this point, for almost any type of cancer, a diagnosis is not a death sentence,” he said. “They’re doing so much research on it, especially with lung cancer… I’ve known people who have lasted 12 to 18 years, so for me, seven years is great. So I’ll just keep going.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

Farooqui echoed the importance of patients “advocating for themselves and getting the most up-to-date therapy there is.”

Continue Reading

Health

Jane Seymour, 75, shares how she approaches aging with vitality: ‘Best I can be’

Published

on

Jane Seymour, 75, shares how she approaches aging with vitality: ‘Best I can be’

NEWYou can now listen to Fox News articles!

At 75, Jane Seymour isn’t fighting the years under her belt — she’s leaning into them. The former Bond girl in “Live and Let Die” and star of “Dr. Quinn, Medicine Woman” has a simple outlook on aging: She’s just grateful for the opportunity.

Her perspective shifted radically in her 40s after a near-death experience involving anaphylactic shock, according to an interview the actress did with Women’s Health.

“I remember looking at my body from above and thinking, ‘That’s your vehicle. I am responsible for taking care of this car,’” Seymour recalled.

COMMON EATING HABIT MAY TRIGGER PREMATURE IMMUNE SYSTEM AGING, STUDY FINDS

Advertisement

The actress shared the following four key habits she uses to navigate her 70s with vitality.

1. Embrace a positive attitude

Seymour’s perspective shifted in her 40s after a near-death experience involving anaphylactic shock, she told Women’s Health. (Michael Loccisano/Getty Images for Elton John AIDS Foundation)

For Seymour, the mental game of aging is just as important as the physical. She said she approaches every day with a sense of optimism, which she describes as “getting up and not giving up.”

In a recent interview with Future of Personal Health, Seymour said that being depressed over lost youth is “redundant.” Instead of mourning the past, she embraces the present.

EXPERTS REVEAL WHY ‘NONNAMAXXING’ TREND MAY IMPROVE MENTAL, PHYSICAL HEALTH

Advertisement

“You were 20, and you had whatever that experience was,” she said. “Now, maybe you’re 70, and it’s a whole new world.”

2. Know your body

Seymour’s fitness routine is built on consistency rather than intensity, she shared. The actress aims to work out at least three times a week, but refuses to push herself to the point of injury.

“You were 20, and you had whatever that experience was,” she said. “Now, maybe you’re 70, and it’s a whole new world.” (Jane Seymour/Instagram)

“I listen to my body,” she told Women’s Health. “I’m not going to overdo it.”

Seymour’s workouts focus on strengthening her core, arms and legs. While her preference is the reformer (a Pilates machine), she is highly adaptable.

Advertisement

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

When traveling without workout equipment, Seymour said she performs bodyweight exercises, even doing incline press-ups against a kitchen counter.

“I’m not going to pretend I’m 20 when I’m 70,” she said. “I’m going to be the best I can be at the age I am.”

3. Nourish your body

Rather than fighting the natural signs of a life well-lived, Seymour said she views her appearance as a professional asset.

Seymour focuses on a rigorous skincare and nutritional routine to maintain the “vehicle” she was given, she said. (Emma Mcintyre/Getty Images)

Advertisement

“I’m not chasing wrinkles,” she added. “My laugh lines and even my frown lines are useful in my work – they’re part of my toolkit.”

TEST YOURSELF WITH OUR LATEST LIFESTYLE QUIZ

The actress said she focuses on a rigorous skincare and nutritional routine to maintain the “vehicle” she was given.

CLICK HERE FOR MORE HEALTH STORIES

This includes a daily regimen of exfoliation and hydration, alongside a diet rich in fruits and vegetables.

Advertisement

“I’m going to be the best I can be at the age I am.”

When her filming schedule makes fresh meals difficult, Seymour supplements with antioxidant blends to ensure there are “no nutritional gaps,” aiming for a holistic balance that allows her to “think sharper and move stronger.”

4. Nourish your mind

Perhaps the most profound tool in Seymour’s toolkit, she said, is her commitment to purpose. Inspired by her mother, a survivor of WWII concentration camps, Seymour believes that longevity is tied to how much one gives back to the world.

Seymour, inspired by her mother, a survivor of WWII concentration camps, created Open Hearts Foundation to give back to the community. (Jane Seymour/Instagram)

“My mother always said there’s someone worse off than you, and you can find purpose by helping others – listening and making them feel heard,” she shared.

Advertisement

CLICK HERE TO DOWNLOAD THE FOX NEWS APP

This philosophy led Seymour to found the Open Hearts Foundation, a nonprofit that empowers others through grant-making and volunteerism.

“That’s the best way to end the day — knowing it wasn’t wasted.”

Continue Reading
Advertisement

Trending